Literature DB >> 22561602

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Kathryn A Seely1, Jeff Lapoint, Jeffery H Moran, Liana Fattore.   

Abstract

"K2" and "Spice" drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as "legal highs". These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate "not for human consumption", the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561602      PMCID: PMC3936256          DOI: 10.1016/j.pnpbp.2012.04.017

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  112 in total

1.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

2.  Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.

Authors:  Andrej Grigoryev; Sergey Savchuk; Aleksandra Melnik; Natal'ja Moskaleva; Jurij Dzhurko; Mihail Ershov; Aleksandr Nosyrev; Aleksandr Vedenin; Boris Izotov; Irina Zabirova; Vladimir Rozhanets
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-26       Impact factor: 3.205

3.  The popularity of "legal highs".

Authors:  Joris C Verster
Journal:  Curr Drug Abuse Rev       Date:  2010-12

4.  Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.

Authors:  John McGrath; Joy Welham; James Scott; Daniel Varghese; Louisa Degenhardt; Mohammad Reza Hayatbakhsh; Rosa Alati; Gail M Williams; William Bor; Jake M Najman
Journal:  Arch Gen Psychiatry       Date:  2010-03-01

Review 5.  Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.

Authors:  Stefan Engeli
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Jun Ogata; Yukihiro Goda
Journal:  Forensic Sci Int       Date:  2010-05-20       Impact factor: 2.395

7.  Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites.

Authors:  Mahmoud A ElSohly; Waseem Gul; Kareem M Elsohly; Timothy P Murphy; Vamsi L M Madgula; Shabana I Khan
Journal:  J Anal Toxicol       Date:  2011-09       Impact factor: 3.367

8.  [Spice drugs: cannabinoids as a new designer drugs].

Authors:  Cristina Mustata; Marta Torrens; Ricardo Pardo; Clara Pérez; Magi Farré
Journal:  Adicciones       Date:  2009       Impact factor: 2.979

9.  Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.

Authors:  J L Wiley; R L Barrett; J Lowe; R L Balster; B R Martin
Journal:  Neuropharmacology       Date:  1995-06       Impact factor: 5.250

10.  Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Authors:  Liana Fattore; Walter Fratta
Journal:  Front Behav Neurosci       Date:  2011-09-21       Impact factor: 3.558

View more
  95 in total

1.  Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

Authors:  S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi
Journal:  Pharmacol Res       Date:  2015-09-08       Impact factor: 7.658

2.  A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.

Authors:  Yildiz Degirmenci; Hulusi Kececi; Nurten Olmez
Journal:  Neurol Sci       Date:  2015-10-14       Impact factor: 3.307

3.  Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.

Authors:  Megan E Patrick; Patrick M O'Malley; Deborah D Kloska; John E Schulenberg; Lloyd D Johnston; Richard A Miech; Jerald G Bachman
Journal:  Drug Alcohol Rev       Date:  2015-12-29

4.  Hemorrhagic stroke following use of the synthetic marijuana "spice".

Authors:  David Z Rose; Waldo R Guerrero; Maxim V Mokin; Clifton L Gooch; Andrea C Bozeman; Julia M Pearson; W Scott Burgin
Journal:  Neurology       Date:  2015-08-28       Impact factor: 9.910

5.  K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

Authors:  Rita G McKeever; David Vearrier; Dorian Jacobs; Gregory LaSala; Jolene Okaneku; Michael I Greenberg
Journal:  J Med Toxicol       Date:  2015-03

6.  Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice.

Authors:  Krishna C Chimalakonda; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Drug Metab Lett       Date:  2013-03

7.  Ischemic stroke after use of the synthetic marijuana "spice".

Authors:  Melissa J Freeman; David Z Rose; Martin A Myers; Clifton L Gooch; Andrea C Bozeman; W Scott Burgin
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

8.  Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Authors:  Isabella Canazza; Andrea Ossato; Claudio Trapella; Anna Fantinati; Maria Antonietta De Luca; Giulia Margiani; Fabrizio Vincenzi; Claudia Rimondo; Fabiana Di Rosa; Adolfo Gregori; Katia Varani; Pier Andrea Borea; Giovanni Serpelloni; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2016-08-15       Impact factor: 4.530

9.  High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.

Authors:  Sameir Alhadi; Anupama Tiwari; Rais Vohra; Roy Gerona; Janak Acharya; Kathryn Bilello
Journal:  J Med Toxicol       Date:  2013-06

10.  Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.

Authors:  Krishna C Chimalakonda; Kathryn A Seely; Stacie M Bratton; Lisa K Brents; Cindy L Moran; Gregory W Endres; Laura P James; Paul F Hollenberg; Paul L Prather; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Drug Metab Dispos       Date:  2012-08-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.